文献速递慢性静脉疾病

慢性静脉阻塞累及股总静脉汇合处:腔内策略与杂交手术的比较

Comparison of endovascular strategy versus hybrid procedure in treatment of chronic venous obstructions involving the confluence of common femoral vein.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2021-08-31

本研究回顾性分析了2015至2020年间102例(108条肢体)因髂股慢性静脉阻塞延伸至股静脉汇合处接受治疗的患者,比较单纯腔内治疗与腔内联合内镜下静脉切除术(杂交)的效果。结果显示两组36个月累积通畅率无显著差异,但腔内治疗组术后并发症更少、手术时间和住院时间更短,临床改善更佳。

要点

  • 对于累及股总静脉汇合处的慢性静脉阻塞,单纯腔内治疗与杂交手术的36个月通畅率相似。
  • 腔内治疗组术后并发症发生率更低,手术时间和住院时间更短。
  • 腔内治疗组临床改善更优,可作为此类患者的优先选择。

核心结论

  • 对于慢性静脉阻塞延伸至股静脉汇合处的患者,单纯腔内治疗与杂交手术的36个月通畅率相似,但腔内治疗术后并发症更少、手术时间和住院时间更短。

研究设计与样本

  • 回顾性队列研究,纳入2015至2020年间连续102例(108条肢体)因髂股慢性静脉阻塞延伸至股静脉汇合处接受治疗的患者。
  • 患者分为杂交手术组(55例,59条肢体)和单纯腔内治疗组(47例,49条肢体),杂交手术组接受支架植入联合股总静脉内镜下静脉切除术并建立动静脉瘘,腔内治疗组仅接受支架植入。

主要发现

  • 两组36个月累积一期通畅率分别为33.7%与36.3%(P = .839),累积辅助一期通畅率分别为59.8%与64%(P = .941),累积二期通畅率分别为69%与72.7%(P = .851),差异均无统计学意义。
  • 腔内治疗组术后并发症发生率更低(P = .012),手术时间更短(P < .001),住院时间更短(P = .025),临床改善更优。

临床怎么用

  • 对于慢性静脉阻塞累及股总静脉汇合处的患者,可优先考虑单纯腔内治疗,因其通畅率与杂交手术相当,且并发症更少、恢复更快。

局限性

  • 本研究为回顾性研究,可能存在选择偏倚,且样本量有限,结论需前瞻性研究进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Treatment of extensive chronic venous obstruction (CVO) with post-thrombotic trabeculation involving the common femoral vein with extension into the femoral vein or deep femoral vein remains a challenge and the best treatment technique for such cases is not clear. In the present study, we compared the results of endovascular alone vs endovascular with additional endophlebectomy (hybrid) procedures for such patients. METHODS: The medical records of 102 consecutive patients (108 limbs) treated between 2015 and 2020 for iliofemoral CVO extending to the femoral confluence were retrospectively reviewed. The patients were divided into two groups: the hybrid procedure (HP) and endovascular treatment (EN) groups. The HP group consisted of those treated with stent implantation and endophlebectomy of the common femoral vein with creation of an arteriovenous fistula. The EN group included those who had undergone stent implantation alone. The patency rates, complications, and clinical outcomes were analyzed. RESULTS: Of the 102 patients, 47 (49 limbs) were in the EN group and 55 (59 limbs) were in the HP group. The demographics of the two groups were similar with no statistically significant differences in cumulative primary, assisted primary, or secondary patency rates at 36 months (33.7% vs 36.3%, P = .839; 59.8% vs 64%, P = .941; 69% vs 72.7%, P = .851; respectively). The patients in the EN group, however, had better clinical improvement with a lower postoperative complication rate (P = .012), shorter procedure duration (P < .001), and shorter hospital stay (P = .025). CONCLUSIONS: The EN and HP both provided similar patency rates for patients with CVO extending into the femoral confluence. The endovascular strategy has the benefit of fewer postoperative complications and a shorter procedure duration and hospital stay compared with the HP.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Piao L, Barbati ME, Shekarchian S, et al. Comparison of endovascular strategy versus hybrid procedure in treatment of chronic venous obstructions involving the confluence of common femoral vein. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 34478907. doi:10.1016/j.jvsv.2021.08.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。